Zinc gluconate versus zinc picolinate: what are the differences?

The zinc gluconate is an active ingredient with the chemical formula C12H22O14Zn. It is particularly known for its sebum-regulating properties, making it an ally for oily skin. From a biological standpoint, zinc gluconate inhibits 5α-reductase, the enzyme catalyzing the conversion of testosterone into dihydrotestosterone (DHT). Binding of DHT to a receptor on sebaceous glands increases their activity and the synthesis of sebum. The zinc gluconate also inhibits the growth of Cutibacterium acnes, a bacterium involved in acne, making it a valuable complement to anti-acne care.

Zinc gluconate is also recognized for its wound-healing properties and its ability to stimulate scar tissue formation. Additionally, its anti-inflammatory activity, which results from its capacity to inhibit the release of TNF-α, a pro-inflammatory cytokine, makes it a valuable agent for soothing skin irritation. Finally, studies have shown that zinc gluconate also finds use in hair care applications and helps to reduce dandruff by eliminating the Malassezia, partly responsible for dandruff, and to prevent hair loss. This last property is explained by its ability to inhibit 5α-reductase, thereby limiting the production of DHT, a hormone that accelerates the transition of hair follicles into the telogen, or shedding, phase.

Beyond these effects, zinc gluconate may also be of interest in the context of atopic dermatitis. This chronic inflammatory condition relies on complex immune mechanisms, including dysfunction of the skin barrier, persistent inflammation, and an imbalanced immune response. Zinc is an essential trace element for the proper functioning of the immune system and the skin barrier. Zinc deficiency can thus weaken the skin and promote the expression of pro-inflammatory mediators, contributing to the exacerbation of atopic lesions.

A study investigated the link between serum zinc levels and the pathophysiology of eczema. The researchers observed that the 168 patients with atopic dermatitis exhibited significantly lower zinc levels than the 137 healthy subjects, associated with an overexpression of the chemokine CXCL10 in the epidermis, a molecule responsible for recruiting immune cells and sustaining skin inflammation.

Administration of zinc gluconate in a murine model reduced CXCL10 release by keratinocytes via activation of PPARα and inhibition of STAT protein phosphorylation involved in inflammatory signaling, thus to attenuate eczema lesions.

These results suggest that zinc gluconate may help modulate skin inflammation in atopic dermatitis, although additional clinical studies are still needed to confirm its benefit in humans.

Zinc picolinate is another derivative of zinc, obtained by chelating picolinic acid with metallic zinc. Its chemical formula is C₁₂H₈N₂O₄Zn. Zinc picolinate is rarely found in cosmetic products, although it can be found in some shampoos, and is more commonly used as a dietary supplement. In this form, it helps address zinc deficiencies and supports immune system function. Zinc picolinate is also included in supplements formulated to support the management of acne, skin inflammations, and certain hair concerns. The properties of zinc picolinate are broadly similar to those of zinc gluconate when taken orally.

Zinc picolinate is most often taken orally because of its high bioavailability. Picolinic acid, a natural metabolite resulting from tryptophan catabolism, serves as an effective chelator and facilitates the intestinal transport of zinc, thereby increasing its absorption.

A comparative study involving fifteen participants evaluated zinc absorption in various forms. It showed that oral intake of zinc picolinate resulted in a slightly higher serum concentration than that observed with zinc gluconate or zinc citrate. After four weeks of supplementation, serum zinc levels reached approximately 0.57 ppm for picolinate, compared with 0.56 ppm for citrate and 0.54 ppm for gluconate. These results should, however, be interpreted with caution due to the small sample size and the fact that only one comparative study is available. Moreover, the observed effects primarily reflect a systemic action from oral supplementation and do not allow conclusions about equivalent efficacy in topical application.

Zinc gluconate and zinc picolinate are two zinc derivatives that share similar biological properties, notably in relation to the regulation of inflammation and sebum production.

When evaluating the choice between zinc gluconate and zinc picolinate, it is crucial to consider not only their effects but also their delivery form and application context. Both can help reduce blemishes, soothe the skin, and support hair health, yet their specific uses differ.

In practice, the question of zinc gluconate versus zinc picolinate arises primarily depending on the route of administration. Zinc picolinate is used almost exclusively as a dietary supplement due to its high bioavailability and excellent intestinal absorption. In contrast, zinc gluconate stands out for its great versatility: it is found in dietary supplements as well as in topical formulations such as creams, lotions, masks, or certain dermatological medications. This compatibility with topical application represents a major advantage of zinc gluconate.

The fact that zinc gluconate is now more widely used than zinc picolinate does not necessarily mean it is inherently more effective. When comparing zinc gluconate to zinc picolinate, the difference largely stems from the amount of scientific documentation available. Zinc gluconate benefits from a larger body of research supporting its use in cosmetic applications. Conversely, clinical studies evaluating the effects of zinc picolinate—particularly on skin and hair—remain more limited and focus primarily on oral supplementation.

Thus, the choice between zinc gluconate and zinc picolinate primarily depends on the intended objective: a localized effect will favor zinc gluconate, while correcting a zinc deficiency or providing systemic support will more likely lead to zinc picolinate.

• BARRON P. & al. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents and Actions (1987).

• KALINOWSKA-LIS U. & al. Zinc-containing compounds for personal care applications. International Journal of Cosmetic Science (2018).

• SCHWARTZ J. & al. Zinc and skin health – Overview of physiology and pharmacology. Journal of Dermatological Treatment (2022).

• AL-NIAIMI F. & al. Zinc in dermatology. Journal of Dermatological Treatment (2022).

• LI D. & al. Zinc gluconate improves atopic dermatitis by modulating CXCL10 release of keratinocytes via PPARα activation. Biomedicine & Pharmacotherapy (2024).